Overview

Study of the Absorption of Vitamin E Water-soluble Form (Pegylated) in the Familial Hypocholesterolemia With Chylomicron Retention

Status:
Completed
Trial end date:
2015-08-01
Target enrollment:
0
Participant gender:
All
Summary
To evaluate the kinetics of intestinal absorption of vitamin E water-soluble form from the classical lipid-soluble form in a population of patients with intestinal malabsorption (hypocholesterolemias family by retention of chylomicrons).
Phase:
Phase 3
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Hospices Civils de Lyon
Treatments:
alpha-Tocopherol
Tocopherols
Tocotrienols
Vitamin E
Vitamins
Criteria
Inclusion Criteria:

- Patient suffering from familial hypocholesterolemia by retention of chylomicrons

- Systematically followed in the department of Gastroenterology and Paediatric Nutrition
in Women Mother Child's Hospital or in the endocrinology department of GHE (Louis
Pradel Hospital);

- During treatment with oral vitamin E;

- over the age of 3 years and weighing over 16 kg at the time of inclusion

- For which there is a signed informed consent from the patient or parents / guardians
in the case of a minor patient, and benefit from social security coverage.

Exclusion Criteria:

- Patient with encephalopathy

- Hypersensitivity to the active substance or the excipients of Vedrop

- A suspected allergy to local anaesthetics (including xylocaine)

- Patients who may not be compliant to treatment (psychiatric);

- In case of refusal to participate in the study from the patient and / or parents or
legal guardian;

- Patients unable to consent (if patients with encephalopathy)